首页>
外文期刊>Advances in BioResearch
>COMPARATIVE STUDY BETWEEN SAUDI AND EGYPTIAN COVID-19 PATIENTS AND COMPLICATIONS ON THE CARDIOVASCULAR AND RESPIRATORY SYSTEMS
【24h】
COMPARATIVE STUDY BETWEEN SAUDI AND EGYPTIAN COVID-19 PATIENTS AND COMPLICATIONS ON THE CARDIOVASCULAR AND RESPIRATORY SYSTEMS
By the end of June 2020, many countries (213) around the world reported about nine millions confirmed cases of the COVID-19 which originated from Wuhan, China, total death (about 472,000).America showed about two million and half confirmed caseswith122,455 deaths.Saudi Arabia showed about 161,000 confirmed cases and about 1,300 death, followed by Egypt about 55,000 confirmed cases and about 2,200 deaths.Respiratory failure due to ARDS is one of the major causes of mortality associated with COVID-19 disease.Acute myocardial injury and could occur in severe patients.In this research we were conducting a comparative study between COVID-19 patients after their recovery from infection in Egypt and Saudi Arabia.From May 2020 for two months we distributed questionnaire consist of 27 questions on Google drive about patient’s demographic (8), cardiovascular (11) and respiratory (8)complications.Also, interviews with Egyptian patients who infected with COVID-19 were done after recovery.About 256 (Saudi) and 120 (Egyptian) patients were participated in this study.Our results showed that 45.7% (Saudis) and 70% (Egyptians) who infected with COVID-19 their age range from 31-50 years old.About 75.8% (Saudis) and 45% (Egyptians) are in contact with patients who are infected with COVID-19.About 31.3% (Saudi) and 5% (Egyptian) patients who are infected with COVID-19 had high heart enzymes.About half of patients with >95% oxygen level either in Saudi and Egyptian patients, while 16.8% (Saudi) and 10% (Egyptian) patients with <85% oxygen who are infected with COVID-19.We can conclude that cardiovascular and respiratory system complications are slightly different from patients in the two countries and also, the prevalence of infection.
展开▼